Colon cancer: feeling the imbalance?

Area of Science:

• Oncology
• Surgical Oncology
• Gastroenterology

Background:

• Neoadjuvant chemotherapy is standard for rectal cancer.
• Recent trials like FOxTROT are driving interest in neoadjuvant chemotherapy for colon cancer.
• Colon cancer management may shift towards chemotherapy intensification, similar to rectal cancer.

Purpose of the Study:

• To explore the implications of upfront chemotherapy in colon cancer management.
• To investigate the role of advanced surgical procedures in the context of neoadjuvant chemotherapy for colon cancer.

Main Methods:

• This study reviews current literature and trial data regarding neoadjuvant chemotherapy in colon and rectal cancers.
• It analyzes the potential impact of neoadjuvant chemotherapy on surgical standards and techniques.

Main Results:

• Neoadjuvant chemotherapy is increasingly considered for colon cancer.
• The FOxTROT trial has significantly influenced this shift.
• The integration of neoadjuvant chemotherapy with radical surgical procedures like complete mesocolic excision requires further investigation.

Conclusions:

• The paradigm for colon cancer treatment is evolving towards neoadjuvant chemotherapy.
• The optimal surgical approach alongside upfront chemotherapy remains an open question.
• Further research is needed to understand the interplay between neoadjuvant chemotherapy and surgical radicality in colon cancer.